`

Tagged: clinical development

BBCR’s SCIO method aims to learn, predict and make better decisions for a successful drug opportunity.

February 21st, 2023 | clinical development

Learn the potentials of each preclinical asset, and predict the level of certainty for each strategic option. Today’s technological molecules require innovation in the development process. We cannot keep using yesterday’s assumptions for tomorrow’s drugs. Marketed product evidence proves that identical molecules developed by different sponsors generated very different drug opportunities. Data show that options’ […]

BBCR specializes in rare disease, working with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process in order to achieve optimal product market positioning.

July 27th, 2022 | clinical development

Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements. Click the button below to learn more about how we have helped companies with their clinical trial needs.    

BBCR works with clients beyond consulting, to create cost-effective clinical trials and strategies that nurture product strengths

November 11th, 2021 | clinical development

Streamlined Clinical Development Strategies Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements. Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process. […]

BBCR embraces innovative strategy consulting for effective clinical development plan and regulatory strategy. Reach out today to learn more about how we can help advance your project.

September 15th, 2021 | clinical development

Our industry needs innovative strategies, and reduced-risk clinical trials. BBCR clinical development services and drug development consulting integrates real world evidence into clinical development plans and regulatory strategies. Focus must go to cost containment and value-based developments that allow sponsors to move more treatments to market faster. BBCR’s team expertise in rare diseases and precision […]

In rare diseases and precision medicine, implementation of biomarkers during product translation into clinic and early clinical development moves treatment to market faster. BBCR is experienced in helping you understand the role of biomarkers and how to move your product to market more efficiently.

February 24th, 2021 | clinical development

Biomarkers are considered a routine part of drug development. Learn more about how BBCR can help get your product to market more efficiently with proper plan development and strategy. Plan Development Insightful strategy is the most effective way to ensure quality when including biomarkers into your product development plan.   Validation or Qualification Understanding where […]

BBCR Streamlines Clinical Development with the Clinical and Regulatory Expertise to Support Your Development Needs

May 28th, 2020 | clinical development

BBCR Consulting offers world-class regulatory, clinical research, and biomarker consulting services that provide high-value, and support our clients’ operational and functional needs. Our process is designed to maximize time efficiencies, risk mitigation, and cost savings. We partner with domestic and international, small-to-medium drug and device companies that are entering early clinical development. BBCR is dedicated […]

Could Seamless Adaptive Designs Advance Rare Disease Clinical Trial Design?

July 24th, 2019 | clinical development

Understanding Personalized Medicine

June 26th, 2019 | clinical development

Patient-Centricity: Empower and inform patients making them partners in the research process

June 5th, 2019 | clinical development

BBCR Consulting announces the first edition of comprehensive insights into biomarker discovery and development.

May 30th, 2019 | clinical development
Handbook of Biomarkers

Pin It on Pinterest